Primary Country (Mandatory)

Other Country (Optional)

Set News Language for United States

Primary Language (Mandatory)
Other Language[s] (Optional)
No other language available

Set News Language for World

Primary Language (Mandatory)
Other Language(s) (Optional)

Set News Source for United States

Primary Source (Mandatory)
Other Source[s] (Optional)

Set News Source for World

Primary Source (Mandatory)
Other Source(s) (Optional)
  • Countries
    • India
    • United States
    • Qatar
    • Germany
    • China
    • Canada
    • World
  • Categories
    • National
    • International
    • Business
    • Entertainment
    • Sports
    • Special
    • All Categories
  • Available Languages for United States
    • English
  • All Languages
    • English
    • Hindi
    • Arabic
    • German
    • Chinese
    • French
  • Sources
    • India
      • AajTak
      • NDTV India
      • The Hindu
      • India Today
      • Zee News
      • NDTV
      • BBC
      • The Wire
      • News18
      • News 24
      • The Quint
      • ABP News
      • Zee News
      • News 24
    • United States
      • CNN
      • Fox News
      • Al Jazeera
      • CBSN
      • NY Post
      • Voice of America
      • The New York Times
      • HuffPost
      • ABC News
      • Newsy
    • Qatar
      • Al Jazeera
      • Al Arab
      • The Peninsula
      • Gulf Times
      • Al Sharq
      • Qatar Tribune
      • Al Raya
      • Lusail
    • Germany
      • DW
      • ZDF
      • ProSieben
      • RTL
      • n-tv
      • Die Welt
      • Süddeutsche Zeitung
      • Frankfurter Rundschau
    • China
      • China Daily
      • BBC
      • The New York Times
      • Voice of America
      • Beijing Daily
      • The Epoch Times
      • Ta Kung Pao
      • Xinmin Evening News
    • Canada
      • CBC
      • Radio-Canada
      • CTV
      • TVA Nouvelles
      • Le Journal de Montréal
      • Global News
      • BNN Bloomberg
      • Métro
Kitchener woman details journey using Ozempic, as weight loss benefits spark rising interest

Kitchener woman details journey using Ozempic, as weight loss benefits spark rising interest

CTV
Saturday, April 15, 2023 08:37:21 PM UTC

A drug originally created for those with Type 2 diabetes is also increasingly becoming a popular way to lose weight.

A drug originally created for those with Type 2 diabetes is also increasingly becoming a popular way to lose weight.

Melissa Sanderson-Alsbergas is a 29-year-old from Kitchener who lives with a chronic illness that makes physical activity a challenge. She came to a crossroad in her weight loss journey when a new prescription was discussed as a potential solution.

“I’m starting to give up,” said Sanderson-Alsbergas. “Then my doctor mentioned Ozempic.”

The drug, a branded version of semaglutide, was intended to help those with diabetes keep their blood sugar level in check. Its popularity has soared in recent months for another one of its effects — doctors are now prescribing the drug for its off-label benefit of weight loss.

“So, it’s been a month now that I’ve been on it and so far I’ve lost about 15 pounds,” Sanderson-Alsbergas explained.

Despite having the ability to help users drop significant weight, professionals are warning about some of the harsh side effects that are associated with the drug.

“In the first 12 weeks of using the drug, you’re so nauseated and uninterested in food that is actually stimulates weight loss,” said Nishta Saxena, a registered dietician with Vibrant Nutrition.

Read full story on CTV
Share this story on:-
More Related News
© 2008 - 2025 Webjosh  |  News Archive  |  Privacy Policy  |  Contact Us